Chlamidia Antibodies Test for Tubal Factor Screening

This study has been completed.
Sponsor:
Information provided by:
Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier:
NCT01406964
First received: July 29, 2011
Last updated: March 30, 2012
Last verified: March 2012

July 29, 2011
March 30, 2012
July 2011
December 2011   (final data collection date for primary outcome measure)
Pregnancy outcome using the two different treatments. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Pregnancy rate, cumulative pregnancy rate and ectopic pregnancy rate in order to evaluate de usefulness of the CAT test as a predictor of tubal pathology.
Same as current
Complete list of historical versions of study NCT01406964 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Chlamidia Antibodies Test for Tubal Factor Screening
Chlamidia Antibodies Test for Tubal Factor Screening

The aim of this study is to evaluate the usefulness of a Chlamydia Antibody Test for screening of tubal factor in patients who undergo artificial insemination.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Sterility
  • Other: CAT test
    A CAT test is performed in order to diagnose tubal factor causes
  • Other: Histerosalpingography
    A Histerosalpingography is performed.
  • Experimental: Arm A
    Arm A performs a CAT test to study tubal factor causes
    Intervention: Other: CAT test
  • Experimental: Arm B
    In Arm B a histerosalpingography is performed.
    Intervention: Other: Histerosalpingography
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
December 2011
December 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age < 38 years
  • FSH < 12.
  • Treatment intrauterine insemination

Exclusion Criteria:

  • Insulin dependent diabetes
  • Thyroid disease
  • Severe male factor
  • Policystic ovarian syndrome
  • Previous abdominal or uterine surgery
  • Prevous abdominal or genital infections
  • Uterine myomas
  • Hidrosalpinx
  • Uterine congenital abnormalities
Female
18 Years to 38 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Spain
 
NCT01406964
VLC-JD-0904-025
No
Dr. Juan Giles, IVI Valencia
Instituto Valenciano de Infertilidad, Spain
Not Provided
Not Provided
Instituto Valenciano de Infertilidad, Spain
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP